These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36283008)

  • 21. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin for the treatment of irritable bowel syndrome.
    Siah KT; Wong RK; Ho KY
    World J Gastroenterol; 2014 Mar; 20(10):2492-8. PubMed ID: 24627586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Błońska A; Konrad P; Chojnacki J; Chojnacki C
    Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis.
    Chojnacki C; Walecka-Kapica E; Klupińska G; Wachowska-Kelly P; Żylińska K; Winczyk K; Chojnacki J
    Pol Arch Med Wewn; 2012; 122(9):392-7. PubMed ID: 22814406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.
    Brown PM; Drossman DA; Wood AJ; Cline GA; Frazier KS; Jackson JI; Bronner J; Freiman J; Zambrowicz B; Sands A; Gershon MD
    Gastroenterology; 2011 Aug; 141(2):507-16. PubMed ID: 21684281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The urinary 5-hydroxyindole acetic acid and plasma nitric oxide levels in irritable bowel syndrome: a preliminary study.
    Yazar A; Büyükafpar K; Polat G; Pata C; Kanýk A; Tiftik EN; Bağdatoğlu O
    Scott Med J; 2005 Feb; 50(1):27-9. PubMed ID: 15792386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What impact do Rome IV criteria have on patients with IBS in China?
    Wang B; Zhao W; Zhao C; Jin H; Zhang L; Chen Q; Wang B
    Scand J Gastroenterol; 2019 Dec; 54(12):1433-1440. PubMed ID: 31829752
    [No Abstract]   [Full Text] [Related]  

  • 29. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease.
    Midenfjord I; Grinsvall C; Koj P; Carnerup I; Törnblom H; Simrén M
    Neurogastroenterol Motil; 2021 Dec; 33(12):e14156. PubMed ID: 33860970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of exogenous melatonin supplement in ameliorating irritable bowel syndrome severity: A meta-analysis of randomized controlled trials.
    Chen KH; Zeng BY; Zeng BS; Sun CK; Cheng YS; Su KP; Wu YC; Chen TY; Lin PY; Liang CS; Hsu CW; Chu CS; Chen YW; Yeh PY; Wu MK; Tseng PT; Hsu CY
    J Formos Med Assoc; 2023 Mar; 122(3):276-285. PubMed ID: 36257872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review.
    Binienda A; Storr M; Fichna J; Salaga M
    Curr Drug Targets; 2018; 19(15):1774-1781. PubMed ID: 29284389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.
    Katsumata R; Shiotani A; Murao T; Ishii M; Fujita M; Matsumoto H; Haruma K
    Intern Med; 2017; 56(9):993-999. PubMed ID: 28458330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Lindsey PJ; Dekker J; Buurman WA; Masclee AA
    Aliment Pharmacol Ther; 2014 Aug; 40(4):392-402. PubMed ID: 24943480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of melatonin therapy in irritable bowel syndrome: a systematic review.
    Mozaffari S; Rahimi R; Abdollahi M
    Curr Pharm Des; 2010; 16(33):3646-55. PubMed ID: 21128901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
    Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
    Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of patients with Rome IV-defined versus physician-diagnosed irritable bowel syndrome: Longitudinal follow-up study.
    Goodoory VC; Craig OF; Gracie DJ; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 Jun; 34(6):e14282. PubMed ID: 34612560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin and melatonin secretion in postmenopausal women with eating disorders.
    Chojnacki C; Walecka-Kapica E; Błońska A; Winczyk K; Stępień A; Chojnacki J
    Endokrynol Pol; 2016; 67(3):299-304. PubMed ID: 27364373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.